Hyperon,PTD is dishing out around 67.5m shares to EGX holders...

Hyperon,

PTD is dishing out around 67.5m shares to EGX holders plus 15c per share.
Using your value for the company (about $260m including DCF of earnings plus current cash);

164m + 67.5m = 231.5m shares

$260m / 231.5m shares = $1.12

Minus the 15c extra per share = about $1.00.

This is valuing EGX and current pipeline at $0. But of course, they are not worth nothing.

I believe $1.00 should be about the base price. I reckon it will keep heading this way until some good news comes out.
Same old problem with biotechs; how do you value potential??

I will probably think about getting in at $1.20 - $1.30. This is based on simple calculation of diluting the pre-takeover hype price for both and diluting it by the number of shares on issue. In other words, I am assuming the old price a few months ago was fair enough for the market so it might be fair enough again. I also thick 20-30c is fair value for their intellectual property given what they sold domantis for.
Risky stuff.

whatdaya yeckon?